SlideShare ist ein Scribd-Unternehmen logo
1 von 13
Downloaden Sie, um offline zu lesen
1
Juliette van den Dolder, PhD
CEO
The solution in 3D cell culturing
2
Noviocell, spin-off from Radboud
• Spin-off: founded Nov 2015
• Prof A. Rowan, Dept Molecular Chemistry,
RU Prof W. Feitz & Dr E. Oosterwijk, Dept
Urology, RIMLS, Radboud UMC
• Our mission is to accelerate life science
research in (stem) cell growth and
differentiation by making 3D cell culture
feasible for every (stem) cell biology
researcher.
• Polyisocyanopeptide (PIC) hydrogel is a fully
synthetic biomimetic extracellular matrix
with identical biomechanical properties as
natural matrices
3
Challenge: Lack of effective cancer therapies
• For example, there is no adequate cure for pancreatic cancer at the
moment and the survival rate of pancreatic cancer is extremely low,
estimated around 3-6 % after 5 years.
• The use of organoids is considered to be the solution to accelerate the
development of new therapies for pancreatic cancer.
• Organoid technologies have significant potential as effective patient
avatars
• Tumor organoids and matching
normal organoids identify associations
between: oncogenic drivers, gene-drug
interactions, efficacy of drugs and
other therapies
Cerebral organoid
M. Lancaster et al.
4
Stem cell researchers need 3D scaffold to mimic
human nature
• 3D mini-organs or organoids for diagnostics or personal medicine
• Currently, natural ECM materials like mouse tumor derived
scaffolds or bovine collagen are used
3D human organs2D cell culture ware
5
Natural gels cannot be used for clinical
applications
Drawbacks Natural matrices (Matrigel)
Batch to batch variation - their exact composition
cannot be defined
Pathogen transmission and immunogenicity
Technical challenges in handling - difficulties in cell
or organoid isolation
Technical challenges with downstream processing
after culturing - imaging
Experimental inertness - inability to experimentally
vary composition
Due to their composition, they cannot be used for
clinical applications
6
The solution: synthetic hydrogel PIC hydrogel
hotcold
Advantages of PIC hydrogel
No batch to batch variation – because of
synthetic origin
Excellent cell growth and differentiation
Biomechanical properties similar to
natural matrices - same elasticity as
collagen
Easy to use - reversible thermosensitive
no difficulties in cell or organoid isolation
& no difficulties with down stream
processing or imaging after culturing
Biofunctionality - make your own
functional hydrogel by clicking your
growth factor of choice to the polymer
Biodegradable and non-toxic
7
Mimic architecture of Extracellular Matrix
A. Representation of the hydrogen-bond network that stabilizes the secondary
helical structure of the PIC.
B. The structure of the PIC hydrogel visualised with atomic force microscopy.
C. Comparison of the stiffness of PIC vs. different natural matrices as a function of
stress .
8
Stem cells respond to extracellular matrix
Discher et al. Science 2009, 324, 1673; Yamada et al. Cell 2006, 126, 645.;
R. Das, O. Zouani Biomaterials 2014, 35, 5278.
Substrate StiffnessAfter
4 days
Neuron Myoblast Osteoblast
Huebsch et al.
Cell 2006, 126, 677
9
Increasing critical stress in polymer gels (P1 to P6)
Lipid droplets in cells (indicating adipogenic commitment) by Oil
Red O staining (Scale bar: 10 µm)
hMSCs commitment analysis after 4 days
Experiment indicates preferential adipogenesis in gels with lower critical stress; gels with
higher critical stress favor osteogenesis
Das RK, Rowan AE. Nat Mater.2015
10
RUO products Diagnostic products Therapeutic products
2016 2018 2021 2026
Sales & marketingProduct development
R&D + product development Sales & marketing
R&D + product development
Sales &
marketing
Business model & Market approach
11
The current market is dominated by Matrigel®
Matrigel:
 ±70% market share (market share> 95% scientific
publications)
 Worldwide revenue ± €160M
3D cell culture market:
• is worth €433 million in 2015, estimated to reach €1.5
billion by 2024 with a CAGR of 14.8%. Scaffold-based
technologies account for a revenue share of over 40%.
12
PIC hydrogel the best alternative for Matrigel
Analysis of synthetic competitors
Puramatrix Hystem Mebiol Hydromatrix Noviogel
Synthetic + + + + +
No chemicals or
enzymes
- - + - +
No crosslinking + - + + +
Tune able strain
stiffness
- - - - +
Tune able
biofunctionality
+ - - - +
Reversible
thermosensitivity
- - + - +
13
Take home message
Contact details:
Juliette van den Dolder
+31 (0)6 46155064
j.vandendolder@noviocell.com
Reinier Postlaan 2
6525 GC Nijmegen
The Netherlands
• PIC hydrogel is an innovative
solution for 3D cell culture and
future clinical applications
• Innovative product in a fast
growing market that are
unmatched by our
competitors

Weitere ähnliche Inhalte

Andere mochten auch

Smb 25092014 helma rutjes pivot park
Smb 25092014 helma rutjes   pivot parkSmb 25092014 helma rutjes   pivot park
Smb 25092014 helma rutjes pivot parkSMBBV
 
Food buddy
Food buddyFood buddy
Food buddySMBBV
 
160630 ampleon rob hoeben (company presentation)
160630 ampleon rob hoeben (company presentation)160630 ampleon rob hoeben (company presentation)
160630 ampleon rob hoeben (company presentation)SMBBV
 
161020 e nose presentatie wat betekent crowdfunding voor de enose
161020 e nose presentatie wat betekent crowdfunding voor de enose161020 e nose presentatie wat betekent crowdfunding voor de enose
161020 e nose presentatie wat betekent crowdfunding voor de enoseSMBBV
 
Bedside diagnostics
Bedside diagnosticsBedside diagnostics
Bedside diagnosticsSMBBV
 
20140828 future chemistry pieter nieuwland
20140828   future chemistry pieter nieuwland20140828   future chemistry pieter nieuwland
20140828 future chemistry pieter nieuwlandSMBBV
 
161020 zorgfunders presentatie crowdfunding, meer dan investeren
161020 zorgfunders presentatie crowdfunding, meer dan investeren161020 zorgfunders presentatie crowdfunding, meer dan investeren
161020 zorgfunders presentatie crowdfunding, meer dan investerenSMBBV
 
20160126 smb avivia hans platteeuw
20160126 smb avivia hans platteeuw20160126 smb avivia hans platteeuw
20160126 smb avivia hans platteeuwSMBBV
 
20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalkenSMBBV
 
20160126 smb innatos maarten vd zanden
20160126 smb innatos maarten vd zanden20160126 smb innatos maarten vd zanden
20160126 smb innatos maarten vd zandenSMBBV
 
20150402 inno boot ij5lab
20150402 inno boot   ij5lab20150402 inno boot   ij5lab
20150402 inno boot ij5labSMBBV
 
20150318 smb hve quirem medical jan sigger
20150318 smb hve quirem medical   jan sigger20150318 smb hve quirem medical   jan sigger
20150318 smb hve quirem medical jan siggerSMBBV
 

Andere mochten auch (12)

Smb 25092014 helma rutjes pivot park
Smb 25092014 helma rutjes   pivot parkSmb 25092014 helma rutjes   pivot park
Smb 25092014 helma rutjes pivot park
 
Food buddy
Food buddyFood buddy
Food buddy
 
160630 ampleon rob hoeben (company presentation)
160630 ampleon rob hoeben (company presentation)160630 ampleon rob hoeben (company presentation)
160630 ampleon rob hoeben (company presentation)
 
161020 e nose presentatie wat betekent crowdfunding voor de enose
161020 e nose presentatie wat betekent crowdfunding voor de enose161020 e nose presentatie wat betekent crowdfunding voor de enose
161020 e nose presentatie wat betekent crowdfunding voor de enose
 
Bedside diagnostics
Bedside diagnosticsBedside diagnostics
Bedside diagnostics
 
20140828 future chemistry pieter nieuwland
20140828   future chemistry pieter nieuwland20140828   future chemistry pieter nieuwland
20140828 future chemistry pieter nieuwland
 
161020 zorgfunders presentatie crowdfunding, meer dan investeren
161020 zorgfunders presentatie crowdfunding, meer dan investeren161020 zorgfunders presentatie crowdfunding, meer dan investeren
161020 zorgfunders presentatie crowdfunding, meer dan investeren
 
20160126 smb avivia hans platteeuw
20160126 smb avivia hans platteeuw20160126 smb avivia hans platteeuw
20160126 smb avivia hans platteeuw
 
20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken
 
20160126 smb innatos maarten vd zanden
20160126 smb innatos maarten vd zanden20160126 smb innatos maarten vd zanden
20160126 smb innatos maarten vd zanden
 
20150402 inno boot ij5lab
20150402 inno boot   ij5lab20150402 inno boot   ij5lab
20150402 inno boot ij5lab
 
20150318 smb hve quirem medical jan sigger
20150318 smb hve quirem medical   jan sigger20150318 smb hve quirem medical   jan sigger
20150318 smb hve quirem medical jan sigger
 

Ähnlich wie 161215 presentatie noviocell juliette vd dolder smb meeting

MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016Jonathan Duckworth
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Merck Life Sciences
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...MilliporeSigma
 
Act corporate-bioeuropemarch13
Act corporate-bioeuropemarch13Act corporate-bioeuropemarch13
Act corporate-bioeuropemarch13Company Spotlight
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSRafa Zubair
 
World stem cells & regenerative medicine congress, london, may 22, 2013
World stem cells & regenerative medicine congress, london, may 22, 2013World stem cells & regenerative medicine congress, london, may 22, 2013
World stem cells & regenerative medicine congress, london, may 22, 2013Advanced Cell Technology, Inc.
 
Act corporate-presentation---may-2013---wscrm---print-version
Act corporate-presentation---may-2013---wscrm---print-versionAct corporate-presentation---may-2013---wscrm---print-version
Act corporate-presentation---may-2013---wscrm---print-versionJohn Redaelli
 
Make better drug discovery decisions through collaborative analytics cdd we...
Make better drug discovery decisions through collaborative analytics   cdd we...Make better drug discovery decisions through collaborative analytics   cdd we...
Make better drug discovery decisions through collaborative analytics cdd we...Lixin Liu
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...Medicines Discovery Catapult
 
Four Therapeutic Strategies For Cancer Treatment In Future.pdf
Four Therapeutic Strategies For Cancer Treatment In Future.pdfFour Therapeutic Strategies For Cancer Treatment In Future.pdf
Four Therapeutic Strategies For Cancer Treatment In Future.pdfDoriaFang
 
MRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics DiscoveryMRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics Discoverywarwick_amr
 
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DTranslational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DInsideScientific
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyMilliporeSigma
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyMerck Life Sciences
 
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)Bioprocessing bioanalytics-congress-europe-agenda-18 (1)
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)Tony Couch
 
MetaMax presentation for Skolkovo
MetaMax presentation for SkolkovoMetaMax presentation for Skolkovo
MetaMax presentation for SkolkovoMaxwellBiotech
 

Ähnlich wie 161215 presentatie noviocell juliette vd dolder smb meeting (20)

Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
 
MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016MedImmune Industrial Placement Student Programme 2016
MedImmune Industrial Placement Student Programme 2016
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
Act corporate-bioeuropemarch13
Act corporate-bioeuropemarch13Act corporate-bioeuropemarch13
Act corporate-bioeuropemarch13
 
Stem Cell Meeting on the Mesa, Oct. 29, 2012
Stem Cell Meeting on the Mesa, Oct. 29, 2012Stem Cell Meeting on the Mesa, Oct. 29, 2012
Stem Cell Meeting on the Mesa, Oct. 29, 2012
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
Act corp-pres-may13
Act corp-pres-may13Act corp-pres-may13
Act corp-pres-may13
 
World stem cells & regenerative medicine congress, london, may 22, 2013
World stem cells & regenerative medicine congress, london, may 22, 2013World stem cells & regenerative medicine congress, london, may 22, 2013
World stem cells & regenerative medicine congress, london, may 22, 2013
 
Act corporate-presentation---may-2013---wscrm---print-version
Act corporate-presentation---may-2013---wscrm---print-versionAct corporate-presentation---may-2013---wscrm---print-version
Act corporate-presentation---may-2013---wscrm---print-version
 
Make better drug discovery decisions through collaborative analytics cdd we...
Make better drug discovery decisions through collaborative analytics   cdd we...Make better drug discovery decisions through collaborative analytics   cdd we...
Make better drug discovery decisions through collaborative analytics cdd we...
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
 
Four Therapeutic Strategies For Cancer Treatment In Future.pdf
Four Therapeutic Strategies For Cancer Treatment In Future.pdfFour Therapeutic Strategies For Cancer Treatment In Future.pdf
Four Therapeutic Strategies For Cancer Treatment In Future.pdf
 
MRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics DiscoveryMRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics Discovery
 
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DTranslational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
 
BioEurope Presentation, March 2010
BioEurope Presentation, March 2010BioEurope Presentation, March 2010
BioEurope Presentation, March 2010
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
 
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapyProcess Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
Process Impurities: Don’t Let PEI or HCP Derail Your BioTherapy
 
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)Bioprocessing bioanalytics-congress-europe-agenda-18 (1)
Bioprocessing bioanalytics-congress-europe-agenda-18 (1)
 
MetaMax presentation for Skolkovo
MetaMax presentation for SkolkovoMetaMax presentation for Skolkovo
MetaMax presentation for Skolkovo
 

Mehr von SMBBV

190228 student project science food and health 2018 radboud university (smb m...
190228 student project science food and health 2018 radboud university (smb m...190228 student project science food and health 2018 radboud university (smb m...
190228 student project science food and health 2018 radboud university (smb m...SMBBV
 
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...SMBBV
 
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)190228 pitch student group 1 new crystals cheaper medicines (smb meeting)
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)SMBBV
 
190228 pitch student groep 4 nirly fresh (smb meeting)
190228 pitch student groep 4 nirly fresh (smb meeting)190228 pitch student groep 4 nirly fresh (smb meeting)
190228 pitch student groep 4 nirly fresh (smb meeting)SMBBV
 
190228 pitch student groep 2 diy on cochlear implants (smb meeting)
190228 pitch student groep 2 diy on cochlear implants (smb meeting)190228 pitch student groep 2 diy on cochlear implants (smb meeting)
190228 pitch student groep 2 diy on cochlear implants (smb meeting)SMBBV
 
190129 presentatie stat stories lonneke opsteegh (smb meeting)
190129 presentatie stat stories   lonneke opsteegh (smb meeting)190129 presentatie stat stories   lonneke opsteegh (smb meeting)
190129 presentatie stat stories lonneke opsteegh (smb meeting)SMBBV
 
190129 presentatie onder de bomen floris heukelom (smb meeting)
190129 presentatie onder de bomen   floris heukelom (smb meeting)190129 presentatie onder de bomen   floris heukelom (smb meeting)
190129 presentatie onder de bomen floris heukelom (smb meeting)SMBBV
 
190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)SMBBV
 
190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)SMBBV
 
180927 presentation dhl ali kocer (smb hv meeting)
180927 presentation dhl ali kocer (smb hv meeting)180927 presentation dhl ali kocer (smb hv meeting)
180927 presentation dhl ali kocer (smb hv meeting)SMBBV
 
180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)SMBBV
 
180927 presentation tjoapack dexter tjoa (smb hv meeting)
180927 presentation tjoapack dexter tjoa (smb hv meeting)180927 presentation tjoapack dexter tjoa (smb hv meeting)
180927 presentation tjoapack dexter tjoa (smb hv meeting)SMBBV
 
180703 start updelta on tour slides smb meeting
180703 start updelta on tour slides smb meeting180703 start updelta on tour slides smb meeting
180703 start updelta on tour slides smb meetingSMBBV
 
180703 sit and heat slides smb meeting
180703 sit and heat slides smb meeting180703 sit and heat slides smb meeting
180703 sit and heat slides smb meetingSMBBV
 
180703 pink rf slides smb meeting
180703 pink rf slides smb meeting180703 pink rf slides smb meeting
180703 pink rf slides smb meetingSMBBV
 
180222 presentatie orikami bram ten teuling (smb meeting)
180222 presentatie orikami bram ten teuling (smb meeting)180222 presentatie orikami bram ten teuling (smb meeting)
180222 presentatie orikami bram ten teuling (smb meeting)SMBBV
 
180222 ru student presentation 4 nieuwe oren
180222 ru student presentation 4 nieuwe oren180222 ru student presentation 4 nieuwe oren
180222 ru student presentation 4 nieuwe orenSMBBV
 
180222 ru student presentation 3 low key urine_screening
180222 ru student presentation 3 low key urine_screening180222 ru student presentation 3 low key urine_screening
180222 ru student presentation 3 low key urine_screeningSMBBV
 
180222 ru student presentation 2 object detection for hemispatial neglect pat...
180222 ru student presentation 2 object detection for hemispatial neglect pat...180222 ru student presentation 2 object detection for hemispatial neglect pat...
180222 ru student presentation 2 object detection for hemispatial neglect pat...SMBBV
 
180222 ru student presentation 1 n ox measurement
180222 ru student presentation 1 n ox measurement180222 ru student presentation 1 n ox measurement
180222 ru student presentation 1 n ox measurementSMBBV
 

Mehr von SMBBV (20)

190228 student project science food and health 2018 radboud university (smb m...
190228 student project science food and health 2018 radboud university (smb m...190228 student project science food and health 2018 radboud university (smb m...
190228 student project science food and health 2018 radboud university (smb m...
 
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...190228 pitch student group 3 microresonator platform to detect cancer (smb me...
190228 pitch student group 3 microresonator platform to detect cancer (smb me...
 
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)190228 pitch student group 1 new crystals cheaper medicines (smb meeting)
190228 pitch student group 1 new crystals cheaper medicines (smb meeting)
 
190228 pitch student groep 4 nirly fresh (smb meeting)
190228 pitch student groep 4 nirly fresh (smb meeting)190228 pitch student groep 4 nirly fresh (smb meeting)
190228 pitch student groep 4 nirly fresh (smb meeting)
 
190228 pitch student groep 2 diy on cochlear implants (smb meeting)
190228 pitch student groep 2 diy on cochlear implants (smb meeting)190228 pitch student groep 2 diy on cochlear implants (smb meeting)
190228 pitch student groep 2 diy on cochlear implants (smb meeting)
 
190129 presentatie stat stories lonneke opsteegh (smb meeting)
190129 presentatie stat stories   lonneke opsteegh (smb meeting)190129 presentatie stat stories   lonneke opsteegh (smb meeting)
190129 presentatie stat stories lonneke opsteegh (smb meeting)
 
190129 presentatie onder de bomen floris heukelom (smb meeting)
190129 presentatie onder de bomen   floris heukelom (smb meeting)190129 presentatie onder de bomen   floris heukelom (smb meeting)
190129 presentatie onder de bomen floris heukelom (smb meeting)
 
190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)
 
190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)190129 de groeiversneller oost nl (smb meeting)
190129 de groeiversneller oost nl (smb meeting)
 
180927 presentation dhl ali kocer (smb hv meeting)
180927 presentation dhl ali kocer (smb hv meeting)180927 presentation dhl ali kocer (smb hv meeting)
180927 presentation dhl ali kocer (smb hv meeting)
 
180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)
 
180927 presentation tjoapack dexter tjoa (smb hv meeting)
180927 presentation tjoapack dexter tjoa (smb hv meeting)180927 presentation tjoapack dexter tjoa (smb hv meeting)
180927 presentation tjoapack dexter tjoa (smb hv meeting)
 
180703 start updelta on tour slides smb meeting
180703 start updelta on tour slides smb meeting180703 start updelta on tour slides smb meeting
180703 start updelta on tour slides smb meeting
 
180703 sit and heat slides smb meeting
180703 sit and heat slides smb meeting180703 sit and heat slides smb meeting
180703 sit and heat slides smb meeting
 
180703 pink rf slides smb meeting
180703 pink rf slides smb meeting180703 pink rf slides smb meeting
180703 pink rf slides smb meeting
 
180222 presentatie orikami bram ten teuling (smb meeting)
180222 presentatie orikami bram ten teuling (smb meeting)180222 presentatie orikami bram ten teuling (smb meeting)
180222 presentatie orikami bram ten teuling (smb meeting)
 
180222 ru student presentation 4 nieuwe oren
180222 ru student presentation 4 nieuwe oren180222 ru student presentation 4 nieuwe oren
180222 ru student presentation 4 nieuwe oren
 
180222 ru student presentation 3 low key urine_screening
180222 ru student presentation 3 low key urine_screening180222 ru student presentation 3 low key urine_screening
180222 ru student presentation 3 low key urine_screening
 
180222 ru student presentation 2 object detection for hemispatial neglect pat...
180222 ru student presentation 2 object detection for hemispatial neglect pat...180222 ru student presentation 2 object detection for hemispatial neglect pat...
180222 ru student presentation 2 object detection for hemispatial neglect pat...
 
180222 ru student presentation 1 n ox measurement
180222 ru student presentation 1 n ox measurement180222 ru student presentation 1 n ox measurement
180222 ru student presentation 1 n ox measurement
 

Kürzlich hochgeladen

Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementIris Thiele Isip-Tan
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousKR_Barker
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychologyshantisphysio
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareratilalthakkar704
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11crzljavier
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfhezamzaki1
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxPamela McKinney
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024Traumasoft LLC
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefitssahilgabhane29
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)bishwabandhuniraula
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha KewatNehaKewat
 
Pharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxPharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxCliniminds India
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborHealth Catalyst
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxsandhulove46637
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLyons Health
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdfCompliatric Where Compliance Happens
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxEMADABATHINI PRABHU TEJA
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsIris Thiele Isip-Tan
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxMUKESH PADMANABHAN
 

Kürzlich hochgeladen (20)

Artificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes ManagementArtificial Intelligence: Diabetes Management
Artificial Intelligence: Diabetes Management
 
ACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the CuriousACCA Version of AI & Healthcare: An Overview for the Curious
ACCA Version of AI & Healthcare: An Overview for the Curious
 
Eating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports PsychologyEating Disorders in Athletes I Sports Psychology
Eating Disorders in Athletes I Sports Psychology
 
Assisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCareAssisted Living Care Residency - PapayaCare
Assisted Living Care Residency - PapayaCare
 
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES  11
FINAL PROJECT IN EMPOWERMENT TECHNOLOGIES 11
 
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdfAnatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
Anatomy Shelf Notevbhhhhhhhhhhhhhhhs.pdf
 
Health literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptxHealth literacies in marginalised communities LILAC 24.pptx
Health literacies in marginalised communities LILAC 24.pptx
 
21 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 202421 NEMT Trends & Statistics to Know in 2024
21 NEMT Trends & Statistics to Know in 2024
 
Introduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin BenefitsIntroduction to Evaluation and Skin Benefits
Introduction to Evaluation and Skin Benefits
 
Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)Basics of Giant Cell Tumor of bone (GCTB)
Basics of Giant Cell Tumor of bone (GCTB)
 
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
LARYNGEAL CANCER.pptx  Prepared by Neha KewatLARYNGEAL CANCER.pptx  Prepared by Neha Kewat
LARYNGEAL CANCER.pptx Prepared by Neha Kewat
 
Pharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptxPharmacovigilance audits inspections.pptx
Pharmacovigilance audits inspections.pptx
 
Three Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and LaborThree Keys to a Successful Margin: Charges, Costs, and Labor
Three Keys to a Successful Margin: Charges, Costs, and Labor
 
Identifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptxIdentifying Signs of Mental Health Presentation (1).pptx
Identifying Signs of Mental Health Presentation (1).pptx
 
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete HealthLiving Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
Living Well Every Day: Lyons Wellness Practice | Nurtures Your Complete Health
 
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
2024 Compliatric Webianr Series - Contracts and MOUs from a HRSA Perspective.pdf
 
Diseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptxDiseases of the Respiratory System (J00-J99),.pptx
Diseases of the Respiratory System (J00-J99),.pptx
 
Annual Training
Annual TrainingAnnual Training
Annual Training
 
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, BenefitsArtificial Intelligence in Healthcare: Challenges, Risks, Benefits
Artificial Intelligence in Healthcare: Challenges, Risks, Benefits
 
person with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptxperson with disability and pwd act ppt.pptx
person with disability and pwd act ppt.pptx
 

161215 presentatie noviocell juliette vd dolder smb meeting

  • 1. 1 Juliette van den Dolder, PhD CEO The solution in 3D cell culturing
  • 2. 2 Noviocell, spin-off from Radboud • Spin-off: founded Nov 2015 • Prof A. Rowan, Dept Molecular Chemistry, RU Prof W. Feitz & Dr E. Oosterwijk, Dept Urology, RIMLS, Radboud UMC • Our mission is to accelerate life science research in (stem) cell growth and differentiation by making 3D cell culture feasible for every (stem) cell biology researcher. • Polyisocyanopeptide (PIC) hydrogel is a fully synthetic biomimetic extracellular matrix with identical biomechanical properties as natural matrices
  • 3. 3 Challenge: Lack of effective cancer therapies • For example, there is no adequate cure for pancreatic cancer at the moment and the survival rate of pancreatic cancer is extremely low, estimated around 3-6 % after 5 years. • The use of organoids is considered to be the solution to accelerate the development of new therapies for pancreatic cancer. • Organoid technologies have significant potential as effective patient avatars • Tumor organoids and matching normal organoids identify associations between: oncogenic drivers, gene-drug interactions, efficacy of drugs and other therapies Cerebral organoid M. Lancaster et al.
  • 4. 4 Stem cell researchers need 3D scaffold to mimic human nature • 3D mini-organs or organoids for diagnostics or personal medicine • Currently, natural ECM materials like mouse tumor derived scaffolds or bovine collagen are used 3D human organs2D cell culture ware
  • 5. 5 Natural gels cannot be used for clinical applications Drawbacks Natural matrices (Matrigel) Batch to batch variation - their exact composition cannot be defined Pathogen transmission and immunogenicity Technical challenges in handling - difficulties in cell or organoid isolation Technical challenges with downstream processing after culturing - imaging Experimental inertness - inability to experimentally vary composition Due to their composition, they cannot be used for clinical applications
  • 6. 6 The solution: synthetic hydrogel PIC hydrogel hotcold Advantages of PIC hydrogel No batch to batch variation – because of synthetic origin Excellent cell growth and differentiation Biomechanical properties similar to natural matrices - same elasticity as collagen Easy to use - reversible thermosensitive no difficulties in cell or organoid isolation & no difficulties with down stream processing or imaging after culturing Biofunctionality - make your own functional hydrogel by clicking your growth factor of choice to the polymer Biodegradable and non-toxic
  • 7. 7 Mimic architecture of Extracellular Matrix A. Representation of the hydrogen-bond network that stabilizes the secondary helical structure of the PIC. B. The structure of the PIC hydrogel visualised with atomic force microscopy. C. Comparison of the stiffness of PIC vs. different natural matrices as a function of stress .
  • 8. 8 Stem cells respond to extracellular matrix Discher et al. Science 2009, 324, 1673; Yamada et al. Cell 2006, 126, 645.; R. Das, O. Zouani Biomaterials 2014, 35, 5278. Substrate StiffnessAfter 4 days Neuron Myoblast Osteoblast Huebsch et al. Cell 2006, 126, 677
  • 9. 9 Increasing critical stress in polymer gels (P1 to P6) Lipid droplets in cells (indicating adipogenic commitment) by Oil Red O staining (Scale bar: 10 µm) hMSCs commitment analysis after 4 days Experiment indicates preferential adipogenesis in gels with lower critical stress; gels with higher critical stress favor osteogenesis Das RK, Rowan AE. Nat Mater.2015
  • 10. 10 RUO products Diagnostic products Therapeutic products 2016 2018 2021 2026 Sales & marketingProduct development R&D + product development Sales & marketing R&D + product development Sales & marketing Business model & Market approach
  • 11. 11 The current market is dominated by Matrigel® Matrigel:  ±70% market share (market share> 95% scientific publications)  Worldwide revenue ± €160M 3D cell culture market: • is worth €433 million in 2015, estimated to reach €1.5 billion by 2024 with a CAGR of 14.8%. Scaffold-based technologies account for a revenue share of over 40%.
  • 12. 12 PIC hydrogel the best alternative for Matrigel Analysis of synthetic competitors Puramatrix Hystem Mebiol Hydromatrix Noviogel Synthetic + + + + + No chemicals or enzymes - - + - + No crosslinking + - + + + Tune able strain stiffness - - - - + Tune able biofunctionality + - - - + Reversible thermosensitivity - - + - +
  • 13. 13 Take home message Contact details: Juliette van den Dolder +31 (0)6 46155064 j.vandendolder@noviocell.com Reinier Postlaan 2 6525 GC Nijmegen The Netherlands • PIC hydrogel is an innovative solution for 3D cell culture and future clinical applications • Innovative product in a fast growing market that are unmatched by our competitors